Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference 10 September
Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update 14 August
Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet 04 August
